| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.379 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.377 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.322 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.247 | |
| cytokine production | GO:0001816 | 319 | 0.243 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.201 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.193 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.176 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.163 | |
| mapk cascade | GO:0000165 | 281 | 0.154 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.144 | |
| sulfur compound metabolic process | GO:0006790 | 100 | 0.137 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.135 | |
| negative regulation of hydrolase activity | GO:0051346 | 71 | 0.135 | |
| tubulin complex biogenesis | GO:0072668 | 2 | 0.132 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.131 | |
| negative regulation of complement activation | GO:0045916 | 3 | 0.130 | |
| blood circulation | GO:0008015 | 195 | 0.128 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.128 | |
| oxidation reduction process | GO:0055114 | 342 | 0.126 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.125 | |
| circulatory system process | GO:0003013 | 197 | 0.122 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.121 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.120 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.116 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.116 | |
| negative regulation of protein activation cascade | GO:2000258 | 3 | 0.112 | |
| cofactor metabolic process | GO:0051186 | 80 | 0.110 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.110 | |
| response to nitrosative stress | GO:0051409 | 1 | 0.108 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.105 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.102 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.099 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.099 | |
| cellular modified amino acid metabolic process | GO:0006575 | 63 | 0.098 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.097 | |
| regulation of cytokine biosynthetic process | GO:0042035 | 59 | 0.092 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.089 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.088 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.084 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.083 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.082 | |
| amine metabolic process | GO:0009308 | 45 | 0.082 | |
| cation homeostasis | GO:0055080 | 212 | 0.081 | |
| negative regulation of oxidative stress induced intrinsic apoptotic signaling pathway | GO:1902176 | 4 | 0.080 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.076 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.076 | |
| angiogenesis | GO:0001525 | 201 | 0.075 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.075 | |
| negative regulation of protein processing | GO:0010955 | 79 | 0.074 | |
| regulation of system process | GO:0044057 | 200 | 0.073 | |
| positive regulation of plasminogen activation | GO:0010756 | 2 | 0.071 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.070 | |
| tubulin complex assembly | GO:0007021 | 2 | 0.070 | |
| male gamete generation | GO:0048232 | 285 | 0.069 | |
| glucose metabolic process | GO:0006006 | 92 | 0.068 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.068 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.066 | |
| muscle cell proliferation | GO:0033002 | 52 | 0.065 | |
| regulation of protein processing | GO:0070613 | 96 | 0.063 | |
| camera type eye development | GO:0043010 | 266 | 0.062 | |
| sodium ion export from cell | GO:0036376 | 1 | 0.062 | |
| nitrobenzene metabolic process | GO:0018916 | 1 | 0.061 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.061 | |
| type b pancreatic cell proliferation | GO:0044342 | 10 | 0.060 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.060 | |
| brown fat cell differentiation | GO:0050873 | 36 | 0.059 | |
| ventricular cardiac muscle cell action potential | GO:0086005 | 4 | 0.059 | |
| chemotaxis | GO:0006935 | 247 | 0.059 | |
| hexose metabolic process | GO:0019318 | 98 | 0.058 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.058 | |
| cardiac muscle contraction | GO:0060048 | 32 | 0.057 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.055 | |
| positive regulation of chemotaxis | GO:0050921 | 38 | 0.054 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.054 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.054 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.053 | |
| complement activation | GO:0006956 | 16 | 0.053 | |
| cardiocyte differentiation | GO:0035051 | 87 | 0.052 | |
| negative regulation of endothelial cell apoptotic process | GO:2000352 | 7 | 0.051 | |
| negative regulation of oxidative stress induced cell death | GO:1903202 | 9 | 0.051 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.051 | |
| cellular carbohydrate catabolic process | GO:0044275 | 15 | 0.049 | |
| gland development | GO:0048732 | 330 | 0.048 | |
| embryonic eye morphogenesis | GO:0048048 | 29 | 0.048 | |
| transmembrane transport | GO:0055085 | 412 | 0.048 | |
| heart contraction | GO:0060047 | 93 | 0.048 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.048 | |
| protein maturation | GO:0051604 | 176 | 0.048 | |
| benzene containing compound metabolic process | GO:0042537 | 5 | 0.047 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.047 | |
| negative regulation of endopeptidase activity | GO:0010951 | 44 | 0.047 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.047 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.045 | |
| negative regulation of response to oxidative stress | GO:1902883 | 10 | 0.045 | |
| regulation of cell size | GO:0008361 | 72 | 0.045 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.045 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.044 | |
| response to nutrient levels | GO:0031667 | 109 | 0.044 | |
| heart morphogenesis | GO:0003007 | 178 | 0.044 | |
| fibroblast growth factor production | GO:0090269 | 4 | 0.044 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.044 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.044 | |
| response to oxidative stress | GO:0006979 | 123 | 0.044 | |
| actin filament organization | GO:0007015 | 113 | 0.044 | |
| dna metabolic process | GO:0006259 | 303 | 0.043 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.043 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.043 | |
| response to growth factor | GO:0070848 | 198 | 0.042 | |
| cytokine metabolic process | GO:0042107 | 71 | 0.042 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.042 | |
| positive regulation of angiogenesis | GO:0045766 | 46 | 0.042 | |
| monosaccharide metabolic process | GO:0005996 | 106 | 0.042 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.042 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.042 | |
| cell adhesion | GO:0007155 | 329 | 0.041 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.041 | |
| protein processing | GO:0016485 | 163 | 0.041 | |
| multicellular organism growth | GO:0035264 | 161 | 0.041 | |
| cardiac muscle cell differentiation | GO:0055007 | 69 | 0.040 | |
| response to uv a | GO:0070141 | 1 | 0.040 | |
| vascular process in circulatory system | GO:0003018 | 62 | 0.040 | |
| energy derivation by oxidation of organic compounds | GO:0015980 | 77 | 0.040 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.040 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.039 | |
| positive regulation of cytokine biosynthetic process | GO:0042108 | 40 | 0.039 | |
| negative regulation of sodium ion transmembrane transport | GO:1902306 | 1 | 0.038 | |
| cardiac cell development | GO:0055006 | 41 | 0.038 | |
| cytokine biosynthetic process | GO:0042089 | 68 | 0.037 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.037 | |
| interleukin 1 beta production | GO:0032611 | 30 | 0.037 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.037 | |
| cellular homeostasis | GO:0019725 | 240 | 0.037 | |
| negative regulation of peptidase activity | GO:0010466 | 46 | 0.036 | |
| cell matrix adhesion | GO:0007160 | 68 | 0.036 | |
| coenzyme metabolic process | GO:0006732 | 52 | 0.036 | |
| cation transport | GO:0006812 | 399 | 0.036 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.036 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.035 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.035 | |
| extracellular structure organization | GO:0043062 | 148 | 0.035 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.035 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.035 | |
| regulation of response to oxidative stress | GO:1902882 | 19 | 0.034 | |
| cell junction organization | GO:0034330 | 77 | 0.034 | |
| regulation of cellular response to growth factor stimulus | GO:0090287 | 82 | 0.034 | |
| generation of precursor metabolites and energy | GO:0006091 | 103 | 0.034 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.034 | |
| regulation of intracellular protein transport | GO:0033157 | 82 | 0.034 | |
| spermatogenesis | GO:0007283 | 284 | 0.034 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.034 | |
| regulation of glucose metabolic process | GO:0010906 | 60 | 0.033 | |
| innate immune response | GO:0045087 | 157 | 0.033 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.033 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.033 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.033 | |
| regulation of angiogenesis | GO:0045765 | 81 | 0.033 | |
| regulation of cell growth | GO:0001558 | 91 | 0.032 | |
| response to oxygen levels | GO:0070482 | 62 | 0.032 | |
| cell growth | GO:0016049 | 130 | 0.032 | |
| glutathione metabolic process | GO:0006749 | 16 | 0.031 | |
| regulation of tumor necrosis factor superfamily cytokine production | GO:1903555 | 50 | 0.031 | |
| regulation of fatty acid metabolic process | GO:0019217 | 28 | 0.031 | |
| regulation of cellular carbohydrate metabolic process | GO:0010675 | 75 | 0.031 | |
| glucose homeostasis | GO:0042593 | 128 | 0.031 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.031 | |
| carbohydrate transport | GO:0008643 | 62 | 0.031 | |
| muscle cell development | GO:0055001 | 133 | 0.030 | |
| immune effector process | GO:0002252 | 321 | 0.030 | |
| cartilage development | GO:0051216 | 140 | 0.030 | |
| positive regulation of peptidyl serine phosphorylation | GO:0033138 | 25 | 0.030 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.030 | |
| muscle contraction | GO:0006936 | 101 | 0.030 | |
| myosin filament organization | GO:0031033 | 3 | 0.030 | |
| protein localization to organelle | GO:0033365 | 185 | 0.029 | |
| maintenance of location | GO:0051235 | 89 | 0.029 | |
| regulation of protein transport | GO:0051223 | 163 | 0.029 | |
| myosin filament assembly | GO:0031034 | 2 | 0.029 | |
| symbiosis encompassing mutualism through parasitism | GO:0044403 | 83 | 0.029 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.029 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.029 | |
| multicellular organismal metabolic process | GO:0044236 | 28 | 0.029 | |
| organelle assembly | GO:0070925 | 177 | 0.029 | |
| amide transport | GO:0042886 | 138 | 0.029 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.029 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.029 | |
| intrinsic apoptotic signaling pathway in response to oxidative stress | GO:0008631 | 19 | 0.029 | |
| regulation of the force of heart contraction | GO:0002026 | 17 | 0.028 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.028 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.028 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.028 | |
| lipid catabolic process | GO:0016042 | 69 | 0.028 | |
| transition metal ion homeostasis | GO:0055076 | 54 | 0.028 | |
| monosaccharide transport | GO:0015749 | 58 | 0.028 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.028 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.027 | |
| hormone metabolic process | GO:0042445 | 86 | 0.027 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.027 | |
| mitochondrion organization | GO:0007005 | 134 | 0.027 | |
| regulation of endopeptidase activity | GO:0052548 | 89 | 0.027 | |
| wound healing | GO:0042060 | 157 | 0.026 | |
| complement activation lectin pathway | GO:0001867 | 5 | 0.026 | |
| positive regulation of behavior | GO:0048520 | 40 | 0.026 | |
| negative regulation of fibroblast growth factor production | GO:0090272 | 2 | 0.026 | |
| respiratory tube development | GO:0030323 | 167 | 0.026 | |
| positive regulation of reactive oxygen species biosynthetic process | GO:1903428 | 2 | 0.026 | |
| action potential | GO:0001508 | 78 | 0.026 | |
| positive regulation of natural killer cell mediated immunity | GO:0002717 | 16 | 0.026 | |
| positive regulation of neuron projection development | GO:0010976 | 79 | 0.026 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.026 | |
| striated muscle cell development | GO:0055002 | 125 | 0.026 | |
| tissue remodeling | GO:0048771 | 102 | 0.025 | |
| neutral lipid metabolic process | GO:0006638 | 57 | 0.025 | |
| heart process | GO:0003015 | 94 | 0.025 | |
| retinoid metabolic process | GO:0001523 | 24 | 0.025 | |
| positive regulation of protein kinase b signaling | GO:0051897 | 32 | 0.025 | |
| striated muscle myosin thick filament assembly | GO:0071688 | 1 | 0.025 | |
| striated muscle hypertrophy | GO:0014897 | 24 | 0.025 | |
| establishment of protein localization to organelle | GO:0072594 | 118 | 0.025 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.024 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.024 | |
| i kappab kinase nf kappab signaling | GO:0007249 | 85 | 0.024 | |
| lipid modification | GO:0030258 | 65 | 0.024 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.024 | |
| regulation of protein kinase b signaling | GO:0051896 | 56 | 0.024 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.024 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.024 | |
| tumor necrosis factor production | GO:0032640 | 50 | 0.024 | |
| response to metal ion | GO:0010038 | 47 | 0.024 | |
| muscle tissue development | GO:0060537 | 308 | 0.023 | |
| response to transforming growth factor beta | GO:0071559 | 88 | 0.023 | |
| fat soluble vitamin biosynthetic process | GO:0042362 | 4 | 0.023 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.023 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.023 | |
| regulation of lipoprotein lipase activity | GO:0051004 | 4 | 0.023 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.023 | |
| regulation of ion transmembrane transport | GO:0034765 | 119 | 0.023 | |
| lung development | GO:0030324 | 164 | 0.023 | |
| multicellular organismal aging | GO:0010259 | 24 | 0.023 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.023 | |
| negative regulation of kinase activity | GO:0033673 | 81 | 0.023 | |
| response to inorganic substance | GO:0010035 | 96 | 0.023 | |
| negative regulation of protein maturation | GO:1903318 | 79 | 0.023 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.023 | |
| substantia nigra development | GO:0021762 | 2 | 0.023 | |
| interleukin 1 production | GO:0032612 | 31 | 0.023 | |
| heart growth | GO:0060419 | 45 | 0.023 | |
| regulation of cellular response to oxidative stress | GO:1900407 | 19 | 0.022 | |
| carbohydrate biosynthetic process | GO:0016051 | 74 | 0.022 | |
| nuclear import | GO:0051170 | 95 | 0.022 | |
| epithelial cell development | GO:0002064 | 159 | 0.022 | |
| interspecies interaction between organisms | GO:0044419 | 83 | 0.022 | |
| renal system process involved in regulation of blood volume | GO:0001977 | 4 | 0.022 | |
| regulation of fibroblast growth factor production | GO:0090270 | 4 | 0.022 | |
| muscle system process | GO:0003012 | 141 | 0.022 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.022 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.021 | |
| reactive nitrogen species metabolic process | GO:2001057 | 0 | 0.021 | |
| kidney epithelium development | GO:0072073 | 121 | 0.021 | |
| cellular glucan metabolic process | GO:0006073 | 32 | 0.021 | |
| regulation of ossification | GO:0030278 | 112 | 0.021 | |
| single organism nuclear import | GO:1902593 | 95 | 0.021 | |
| cellular response to peptide hormone stimulus | GO:0071375 | 92 | 0.021 | |
| negative regulation of mapk cascade | GO:0043409 | 65 | 0.021 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.021 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.021 | |
| digestive system development | GO:0055123 | 200 | 0.020 | |
| regulation of lipid catabolic process | GO:0050994 | 15 | 0.020 | |
| monocarboxylic acid biosynthetic process | GO:0072330 | 61 | 0.020 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.020 | |
| regulation of intrinsic apoptotic signaling pathway | GO:2001242 | 61 | 0.020 | |
| response to acid chemical | GO:0001101 | 111 | 0.020 | |
| negative regulation of mesenchymal cell proliferation | GO:0072201 | 3 | 0.020 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.020 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.020 | |
| embryonic limb morphogenesis | GO:0030326 | 126 | 0.020 | |
| urogenital system development | GO:0001655 | 261 | 0.019 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.019 | |
| respiratory system development | GO:0060541 | 190 | 0.019 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.019 | |
| regulation of cellular component size | GO:0032535 | 121 | 0.019 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.019 | |
| t cell proliferation | GO:0042098 | 120 | 0.019 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.019 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.019 | |
| positive regulation of nucleocytoplasmic transport | GO:0046824 | 30 | 0.019 | |
| regulation of complement activation | GO:0030449 | 7 | 0.019 | |
| response to superoxide | GO:0000303 | 16 | 0.019 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.019 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.019 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.019 | |
| metanephric loop of henle development | GO:0072236 | 4 | 0.019 | |
| stem cell differentiation | GO:0048863 | 268 | 0.019 | |
| membrane organization | GO:0061024 | 245 | 0.019 | |
| t cell activation | GO:0042110 | 289 | 0.018 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.018 | |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.018 | |
| cognition | GO:0050890 | 149 | 0.018 | |
| cellular response to peptide | GO:1901653 | 92 | 0.018 | |
| regulation of skeletal muscle contraction | GO:0014819 | 3 | 0.018 | |
| regulation of reactive oxygen species biosynthetic process | GO:1903426 | 2 | 0.018 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.018 | |
| phosphatidylinositol mediated signaling | GO:0048015 | 41 | 0.018 | |
| lymphocyte mediated immunity | GO:0002449 | 139 | 0.018 | |
| intracellular protein transport | GO:0006886 | 204 | 0.018 | |
| positive regulation of fat cell differentiation | GO:0045600 | 32 | 0.018 | |
| hexose transport | GO:0008645 | 56 | 0.018 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.018 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.018 | |
| response to temperature stimulus | GO:0009266 | 55 | 0.018 | |
| midgut development | GO:0007494 | 4 | 0.017 | |
| cellular response to insulin stimulus | GO:0032869 | 78 | 0.017 | |
| response to hypoxia | GO:0001666 | 58 | 0.017 | |
| hexose biosynthetic process | GO:0019319 | 39 | 0.017 | |
| actin filament based movement | GO:0030048 | 23 | 0.017 | |
| positive regulation of growth | GO:0045927 | 104 | 0.017 | |
| glucan metabolic process | GO:0044042 | 32 | 0.017 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.017 | |
| regulation of interleukin 1 production | GO:0032652 | 26 | 0.017 | |
| pyruvate metabolic process | GO:0006090 | 28 | 0.017 | |
| regulation of tumor necrosis factor production | GO:0032680 | 49 | 0.017 | |
| negative regulation of cytokine production | GO:0001818 | 84 | 0.017 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.017 | |
| regulation of transporter activity | GO:0032409 | 57 | 0.017 | |
| regulation of systemic arterial blood pressure | GO:0003073 | 61 | 0.017 | |
| regulation of lipid biosynthetic process | GO:0046890 | 54 | 0.017 | |
| microtubule based process | GO:0007017 | 236 | 0.017 | |
| response to granulocyte macrophage colony stimulating factor | GO:0097012 | 3 | 0.017 | |
| fat cell differentiation | GO:0045444 | 160 | 0.017 | |
| protein import | GO:0017038 | 101 | 0.017 | |
| regulation of secretion | GO:0051046 | 274 | 0.017 | |
| multicellular organismal macromolecule metabolic process | GO:0044259 | 19 | 0.017 | |
| muscle hypertrophy | GO:0014896 | 24 | 0.017 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.017 | |
| regulation of sodium ion transport | GO:0002028 | 29 | 0.017 | |
| cell fate commitment | GO:0045165 | 210 | 0.017 | |
| peptidyl serine modification | GO:0018209 | 83 | 0.016 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.016 | |
| mesenchyme development | GO:0060485 | 152 | 0.016 | |
| negative regulation of protein serine threonine kinase activity | GO:0071901 | 49 | 0.016 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 88 | 0.016 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.016 | |
| regulation of sodium ion transmembrane transport | GO:1902305 | 9 | 0.016 | |
| negative regulation of cellular response to oxidative stress | GO:1900408 | 10 | 0.016 | |
| actin mediated cell contraction | GO:0070252 | 15 | 0.016 | |
| glucose transport | GO:0015758 | 56 | 0.016 | |
| humoral immune response | GO:0006959 | 57 | 0.016 | |
| thyroid stimulating hormone secreting cell differentiation | GO:0060129 | 4 | 0.016 | |
| polysaccharide metabolic process | GO:0005976 | 39 | 0.016 | |
| hormone secretion | GO:0046879 | 128 | 0.016 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.016 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.016 | |
| regulation of oxidative stress induced intrinsic apoptotic signaling pathway | GO:1902175 | 9 | 0.016 | |
| negative regulation of sodium ion transmembrane transporter activity | GO:2000650 | 1 | 0.016 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.016 | |
| hematopoietic stem cell migration | GO:0035701 | 1 | 0.016 | |
| regulation of reproductive process | GO:2000241 | 66 | 0.016 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.016 | |
| heart trabecula formation | GO:0060347 | 14 | 0.016 | |
| diterpenoid metabolic process | GO:0016101 | 24 | 0.016 | |
| regulation of carbohydrate metabolic process | GO:0006109 | 75 | 0.016 | |
| coenzyme a metabolic process | GO:0015936 | 8 | 0.016 | |
| organ growth | GO:0035265 | 117 | 0.016 | |
| regulation of sodium ion transmembrane transporter activity | GO:2000649 | 9 | 0.016 | |
| thioester metabolic process | GO:0035383 | 19 | 0.016 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.016 | |
| neuron projection extension | GO:1990138 | 64 | 0.016 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.016 | |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 106 | 0.016 | |
| renal system process involved in regulation of systemic arterial blood pressure | GO:0003071 | 15 | 0.016 | |
| acyl coa biosynthetic process | GO:0071616 | 7 | 0.016 | |
| regulation of peptide secretion | GO:0002791 | 77 | 0.016 | |
| regulation of cell motility | GO:2000145 | 236 | 0.016 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.015 | |
| nuclear transport | GO:0051169 | 139 | 0.015 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.015 | |
| positive regulation of protein transport | GO:0051222 | 93 | 0.015 | |
| glycolytic process | GO:0006096 | 20 | 0.015 | |
| regulation of endothelial cell proliferation | GO:0001936 | 23 | 0.015 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.015 | |
| regulation of monocyte chemotaxis | GO:0090025 | 3 | 0.015 | |
| response to hydrogen peroxide | GO:0042542 | 32 | 0.015 | |
| regulation of defense response | GO:0031347 | 233 | 0.015 | |
| cell killing | GO:0001906 | 67 | 0.015 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.015 | |
| negative regulation of prostatic bud formation | GO:0060686 | 4 | 0.015 | |
| learning or memory | GO:0007611 | 148 | 0.015 | |
| regulation of cardiac muscle contraction | GO:0055117 | 21 | 0.015 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.015 | |
| regulation of extent of cell growth | GO:0061387 | 52 | 0.015 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.015 | |
| negative regulation of ion transport | GO:0043271 | 28 | 0.015 | |
| endocytosis | GO:0006897 | 168 | 0.015 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.015 | |
| response to xenobiotic stimulus | GO:0009410 | 13 | 0.015 | |
| sodium ion transport | GO:0006814 | 73 | 0.014 | |
| positive regulation of insulin like growth factor receptor signaling pathway | GO:0043568 | 8 | 0.014 | |
| male sex differentiation | GO:0046661 | 109 | 0.014 | |
| embryonic camera type eye development | GO:0031076 | 36 | 0.014 | |
| negative regulation of organelle organization | GO:0010639 | 90 | 0.014 | |
| peptide transport | GO:0015833 | 133 | 0.014 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.014 | |
| prostate gland development | GO:0030850 | 48 | 0.014 | |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.014 | |
| positive regulation of epithelial cell proliferation | GO:0050679 | 68 | 0.014 | |
| positive regulation of proteolysis | GO:0045862 | 85 | 0.014 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.014 | |
| regulation of peptidyl tyrosine phosphorylation | GO:0050730 | 93 | 0.014 | |
| cell cell junction assembly | GO:0007043 | 27 | 0.014 | |
| tissue homeostasis | GO:0001894 | 115 | 0.014 | |
| regulation of muscle adaptation | GO:0043502 | 31 | 0.014 | |
| negative regulation of blood vessel morphogenesis | GO:2000181 | 25 | 0.014 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.014 | |
| female genitalia morphogenesis | GO:0048807 | 3 | 0.014 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.014 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.014 | |
| negative regulation of dna replication | GO:0008156 | 4 | 0.014 | |
| neural nucleus development | GO:0048857 | 22 | 0.014 | |
| activation of immune response | GO:0002253 | 138 | 0.014 | |
| germ cell development | GO:0007281 | 185 | 0.013 | |
| regulation of stem cell proliferation | GO:0072091 | 78 | 0.013 | |
| cardiac muscle fiber development | GO:0048739 | 4 | 0.013 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.013 | |
| regulation of receptor activity | GO:0010469 | 41 | 0.013 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.013 | |
| neuromuscular process controlling balance | GO:0050885 | 59 | 0.013 | |
| gonad development | GO:0008406 | 141 | 0.013 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.013 | |
| response to insulin | GO:0032868 | 100 | 0.013 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.013 | |
| regulation of protein secretion | GO:0050708 | 82 | 0.013 | |
| regulation of cytoplasmic transport | GO:1903649 | 112 | 0.013 | |
| isoprenoid metabolic process | GO:0006720 | 29 | 0.013 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.013 | |
| response to peptide hormone | GO:0043434 | 127 | 0.013 | |
| striated muscle contraction | GO:0006941 | 45 | 0.013 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.013 | |
| skeletal muscle thin filament assembly | GO:0030240 | 2 | 0.013 | |
| skeletal myofibril assembly | GO:0014866 | 4 | 0.013 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.013 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.013 | |
| response to decreased oxygen levels | GO:0036293 | 59 | 0.013 | |
| response to monosaccharide | GO:0034284 | 67 | 0.013 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.013 | |
| positive regulation of heart rate by epinephrine norepinephrine | GO:0001996 | 4 | 0.013 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.013 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.013 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.013 | |
| regulation of cell migration | GO:0030334 | 219 | 0.013 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.012 | |
| actin myosin filament sliding | GO:0033275 | 1 | 0.012 | |
| response to alcohol | GO:0097305 | 48 | 0.012 | |
| ribonucleoside bisphosphate metabolic process | GO:0033875 | 9 | 0.012 | |
| defense response to other organism | GO:0098542 | 197 | 0.012 | |
| renal sodium ion transport | GO:0003096 | 2 | 0.012 | |
| regulation of cytokine secretion | GO:0050707 | 61 | 0.012 | |
| regulation of plasminogen activation | GO:0010755 | 4 | 0.012 | |
| protein targeting | GO:0006605 | 143 | 0.012 | |
| male anatomical structure morphogenesis | GO:0090598 | 4 | 0.012 | |
| purine ribonucleoside monophosphate metabolic process | GO:0009167 | 80 | 0.012 | |
| cardiac muscle cell development | GO:0055013 | 39 | 0.012 | |
| positive regulation of voltage gated calcium channel activity | GO:1901387 | 2 | 0.012 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.012 | |
| negative regulation of intrinsic apoptotic signaling pathway | GO:2001243 | 34 | 0.012 | |
| epithelial tube formation | GO:0072175 | 130 | 0.012 | |
| regulation of cartilage development | GO:0061035 | 44 | 0.012 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.012 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.012 | |
| carbohydrate catabolic process | GO:0016052 | 32 | 0.012 | |
| myofibril assembly | GO:0030239 | 34 | 0.012 | |
| gas homeostasis | GO:0033483 | 3 | 0.012 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.012 | |
| forebrain development | GO:0030900 | 302 | 0.012 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.012 | |
| glycolipid biosynthetic process | GO:0009247 | 13 | 0.012 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.012 | |
